Cartesian Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-18. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.
Showing 25 of 88 people.
| Name | Role | Location |
|---|---|---|
| Goran Kei Ando | Director | WATERTOWN, MA |
| Timothy Kei Barabe | Director | WATERTOWN, MA |
| Carrie Kei Cox | Director | WATERTOWN, MA |
| Scott Kei Myers | Director | WATERTOWN, MA |
| Aymeric Kei Sallin | Director | WATERTOWN, MA |
| Timothy Kei Springer | Director | WATERTOWN, MA |
| Patrick Kei Zenner | Director | WATERTOWN, MA |
| Bradford D Dahms | Executive Officer | WATERTOWN, MA |
| Lloyd D Johnston | Executive Officer | WATERTOWN, MA |
| Takashi Kei Kishimoto | Executive Officer | WATERTOWN, MA |
| Elona Kei Kogan | Executive Officer | WATERTOWN, MA |
| Stephen Kei Smolinksi | Executive Officer | WATERTOWN, MA |
| CARL GORDON | Director | SAN DIEGO, CA |
| Werner Cautreels | Director | Waltham, MA |
| Werner Cautreels | Executive Officer | Waltham, MA |
| Timothy A Springer | Director | Watertown, MA |
| Chris A Jewell | Executive Officer | Gaithersburg, MD |
| Michael C Singer | Director | Gaithersburg, MD |
| Kemal C Malik | Director | Gaithersburg, MD |
| Carsten Brunn | Director | Gaithersburg, MD |
| Carsten Brunn | Executive Officer | Gaithersburg, MD |
| Metin A Kurtoglu | Executive Officer | Gaithersburg, MD |
| Timothy C Barabe | Director | Gaithersburg, MD |
| Nishan C de Silva | Director | Gaithersburg, MD |
| Patrick A Zenner | Director | Gaithersburg, MD |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-07-17 | D | $130.0M | $130.0M |
| 2023-12-04 | D/A | $60.3M | $60.3M |
| 2023-12-01 | D | $60.3M | $60.3M |
| 2020-01-02 | D | $70.0M | $70.0M |
| 2019-09-04 | D | $5.8M | $5.8M |
| 2017-07-11 | D | $50.0M | $50.0M |
| 2016-12-14 | D | $5.0M | $5.0M |
| 2015-09-10 | D | $40.6M | $37.4M |
| 2015-04-23 | D | $7.5M | $5.9M |
| 2014-08-28 | D | $4.5M | $4.5M |
| 2014-07-15 | D | $6.0M | $6.0M |
| 2014-04-09 | D | $10.0M | $5.3M |
| 2011-11-17 | D | $26.0M | $3.5M |
| 2011-11-17 | D | $22.0M | $22.0M |
| 2010-04-06 | D | $15.0M | $15.0M |